Children exposed to chemotherapy during the prenatal period appear to develop as well as those in the general population, without increased cardiac or neurologic morbidity. Medscape Medical News
Dr. Maurie Markman reviews a new study looking at the effect of TP53 mutations on outcomes after fludarabine-based chemotherapy in patients with chronic lymphocytic leukemia. Medscape Genomic Medicine